Fabrinet vs Philip Morris International Inc. — how do they compare? Fabrinet trades at $465.82 (market cap $17.44B), while Philip Morris International Inc. trades at $185.66 (market cap $281.91B). The key difference: Philip Morris International Inc. is far larger — about 16.2× Fabrinet's market cap, and Philip Morris International Inc. pays a 3.25% dividend while Fabrinet pays none. Which is the better fit depends on your goals.
| FN | PM | |
|---|---|---|
Market Cap | $17.44B | $281.91B |
Sector | Technology | Consumer Staples |
52-Week High | $746.47 | $191.86 |
52-Week Low | $277.04 | $144.33 |
Enterprise Value | $16.50B | $328.41B |
Dividend Yield | — | 3.25% |
Signals from Pluang's Aura AI — not financial advice
Fabrinet (FN) trades at $474.19, down 1.78% on the day, with a bearish technical signal despite strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.72 exceeding expectations. Analyst consensus remains strongly bullish with a $733 price target, though technical indicators show selling pressure with support at $473 and resistance at $484.
FN presents a compelling growth story driven by AI infrastructure demand, with revenue projected to grow from $3.42B to $4.2B in 2026. However, premium valuation metrics (P/E 41.81, P/B 7.57) and technical bearishness create near-term headwinds. The risk-reward favors long-term investors given the company's strategic positioning in optical communications and debt-free balance sheet.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →